Raquel Aguado-Rivas
Research Subjects
Raquel Aguado-Rivas has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ana Checa-Ros
Grupo de Investigación en Enfermedades Cardiorrenales y Metabólicas, Departamento de Medicina y Cirugía, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera-CEU, CEU Universities, C/Santiago Ramón y Cajal s/n, 46115 Valencia, Spain
2 shared publications - Antonio Molina-Carballo
Unit of Pediatric Neurology and Neurodevelopment, Clínico San Cecilio University Hospital, Andalusian Health Service, Granada Spain; Department of Pediatrics, School of Medicine, University of Granada Spain; Biohealth Research Institute Granada (ibs.GRANADA), University Hospital of Granada, 18016, Spain Granada, Spain
2 shared publications Ana Fernández-Ibañez
Biohealth Research Institute Granada (ibs.GRANADA), University Hospital of Granada, 18016, Spain Granada, Spain
1 shared publication- Darío Acuña-Castroviejo
Centro de Investigación Biomédica, Facultad de Medicina, Departamento de Fisiología, Instituto de Biotecnología, Parque Tecnológico de Ciencias de la Salud Universidad de Granada Granada Spain
1 shared publication Francisco Contreras-Chova
Unit of Pediatric Neurology and Neurodevelopment, Clínico San Cecilio University Hospital, Andalusian Health Service, Granada Spain
1 shared publication- Laura Garre-Morata
Biohealth Research Institute Granada (ibs. GRANADA), University Hospital of Granada, 18016 Granada, Spain
1 shared publication
Latest Publications
- Open Access
- 21 March 2026
- Published by Elsevier in Psychiatry Research
- Vol. 360, 117111
Steroid/thyroid hormones and inflammatory markers in adolescents with ADHD: comparisons with healthy controls and modifications by methylphenidate
- 21 March 2026
- Published by Elsevier in Psychiatry Research
- Vol. 360, 117111
Open AccessSteroid/thyroid hormones and inflammatory markers in adolescents with ADHD: comparisons with healthy controls and modifications by methylphenidate
- Open Access
- 9 August 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (8) , 1818
Differences in the Interleukin Profiles in Inattentive ADHD Prepubertal Children Are Probably Related to Conduct Disorder Comorbidity
Inflammatory cytokines are involved in attention deficit hyperactivity disorder (ADHD), a highly prevalent neurodevelopmental disorder. To quantify the baseline levels of pro- and anti-inflammatory cytokines and their changes after methylphenidate (MPH), a total of 31 prepubertal children with ADHD were recruited and subclassified into only two ADHD presentations—ADHD attention deficit (n = 13) or ADHD combined (n = 18). The children were also screened for oppositional defiant conduct disorder (ODCD) and anxiety disorder. Blood samples were drawn at 09:00 and after 4.63 ± 1.87 months of treatment. Four pro-inflammatory cytokines (interleukin-1beta (IL-1β), IL-5, IL-6, tumor necrosis factor-alpha (TNF-α)) and three anti-inflammatory cytokines (IL-4, IL-10, IL-13) were measured using a Luminex® assay. For statistics, a factorial analysis was performed in Stata 15.1. Overall, there were no statistically significant differences in the interleukin (IL) values induced by treatment. When grouped by presentation, the differences were present almost exclusively in ADHD-AD, usually with a profile opposite to that observed in ADHD-C, and with interactions between comorbid factors, with IL-1β (p = 0.01) and IL-13 (p = 0.006) being the ones reaching the greatest statistical significance. These differences are probably related to the ODCD factor, and they disappear after treatment. In conclusion, the changes observed in cytokine levels in prepubertal children only in the ADHD-AD presentation are probably related to comorbidities (specifically ODCD) and are mitigated after treatment.
- 9 August 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (8) , 1818
Open AccessDifferences in the Interleukin Profiles in Inattentive ADHD Prepubertal Children Are Probably Related to Conduct Disorder Comorbidity
Inflammatory cytokines are involved in attention deficit hyperactivity disorder (ADHD), a highly prevalent neurodevelopmental disorder. To quantify the baseline levels of pro- and anti-inflammatory cytokines and their changes after methylphenidate (MPH), a total of 31 prepubertal children with ADHD were recruited and subclassified into only two ADHD presentations—ADHD attention deficit (n = 13) or ADHD combined (n = 18). The children were also screened for oppositional defiant conduct disorder (ODCD) and anxiety disorder. Blood samples were drawn at 09:00 and after 4.63 ± 1.87 months of treatment. Four pro-inflammatory cytokines (interleukin-1beta (IL-1β), IL-5, IL-6, tumor necrosis factor-alpha (TNF-α)) and three anti-inflammatory cytokines (IL-4, IL-10, IL-13) were measured using a Luminex® assay. For statistics, a factorial analysis was performed in Stata 15.1. Overall, there were no statistically significant differences in the interleukin (IL) values induced by treatment. When grouped by presentation, the differences were present almost exclusively in ADHD-AD, usually with a profile opposite to that observed in ADHD-C, and with interactions between comorbid factors, with IL-1β (p = 0.01) and IL-13 (p = 0.006) being the ones reaching the greatest statistical significance. These differences are probably related to the ODCD factor, and they disappear after treatment. In conclusion, the changes observed in cytokine levels in prepubertal children only in the ADHD-AD presentation are probably related to comorbidities (specifically ODCD) and are mitigated after treatment.